BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Khoury T, Ben Ya'acov A, Shabat Y, Zolotarovya L, Snir R, Ilan Y. Altered distribution of regulatory lymphocytes by oral administration of soy-extracts exerts a hepatoprotective effect alleviating immune mediated liver injury, non-alcoholic steatohepatitis and insulin resistance. World J Gastroenterol 2015; 21(24): 7443-7456 [PMID: 26139990 DOI: 10.3748/wjg.v21.i24.7443]
URL: https://www.wjgnet.com/1007-9327/full/v21/i24/7443.htm
Number Citing Articles
1
Yubing Li, Xinyu Deng, Xiaochuan Guo, Fangling Zhang, Hefei Wu, Xuhua Qin, Xiao Ma. Preclinical and clinical evidence for the treatment of non-alcoholic fatty liver disease with soybean: A systematic review and meta-analysisFrontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1088614
2
Elisa Mascolo, Fiammetta Vernì. Vitamin B6 and Diabetes: Relationship and Molecular MechanismsInternational Journal of Molecular Sciences 2020; 21(10): 3669 doi: 10.3390/ijms21103669
3
Tawfik Khoury, Dory Rotnemer-Golinkin, Lidya Zolotarev, Yaron Ilan. Orally administered anti-eotaxin-1 monoclonal antibody is biologically active in the gut and alleviates immune-mediated hepatitis: A novel anti-inflammatory personalized therapeutic approachInternational Journal of Immunopathology and Pharmacology 2021; 35: 205873842110212 doi: 10.1177/20587384211021215
4
Tawfik Khoury, Devorah Rotnemer-Golinkin, Yehudit Shabat, Lidya Zolotarovya, Yaron Ilan. Oral Co-administration of Soy-derived Extracts with Alcohol or with Sugar-sweetened Beverages Exerts Liver and Sugar Protective EffectsJournal of Clinical and Translational Hepatology 2017; (XX): 1 doi: 10.14218/JCTH.2017.00019
5
Yehudit Shabat, Ami Ben Ya’acov, Yaron Ilan. Alpha-1 Anti-trypsin Exerts a Hepatoprotective Effect on Immune-mediated Hepatitis and Acetaminophen-induced Liver InjuryJournal of Clinical and Translational Hepatology 2018; 6(4): XX doi: 10.14218/JCTH.2018.00030
6
Y. Ilan. Review article: novel methods for the treatment of non-alcoholic steatohepatitis - targeting the gut immune system to decrease the systemic inflammatory response without immune suppressionAlimentary Pharmacology & Therapeutics 2016; 44(11-12): 1168 doi: 10.1111/apt.13833
7
Ariel Drori, Dvorah Rotnemer-Golinkin, Lidya Zolotarov, Yaron Ilan. Oral Administration of CardioAid and Lunasin Alleviates Liver Damage in a High-Fat Diet Nonalcoholic Steatohepatitis ModelDigestion 2017; 96(2): 110 doi: 10.1159/000479734
8
Huriatul Masdar, Tommy Satriyasumatri, M. Radiatul Hakiki, Muhammad Rafisyahputra, Desby Juananda. Histological apperarance of diabetes-rat pancreas administrated by soybean compared to tempehINTERNATIONAL CONFERENCE ON BIOINFORMATICS AND NANO-MEDICINE FROM NATURAL RESOURCES FOR BIOMEDICAL RESEARCH: 3rd Annual Scientific Meeting for Biomedical Sciences 2019; 2108: 020012 doi: 10.1063/1.5109987
9
Meichan Yang, Deqiang Zhang, Zifeng Zhao, Julian Sit, Mischael Saint‐Sume, Omar Shabandri, Kezhong Zhang, Lei Yin, Xin Tong. Hepatic E4BP4 induction promotes lipid accumulation by suppressing AMPK signaling in response to chemical or diet‐induced ER stressThe FASEB Journal 2020; 34(10): 13533 doi: 10.1096/fj.201903292RR
10
Yuval Ishay, Joel Neutel, Yotam Kolben, Ram Gelman, Orly Sneh Arbib, Oliver Lopez, Helena Katchman, Rizwana Mohseni, Miriam Kidron, Yaron Ilan. Oral Insulin Alleviates Liver Fibrosis and Reduces Liver Steatosis in Patients With Metabolic Dysfunction-associated Steatohepatitis and Type 2 Diabetes: Results of Phase II Randomized, Placebo-controlled Feasibility Clinical TrialGastro Hep Advances 2024; 3(3): 417 doi: 10.1016/j.gastha.2023.11.016
11
Yuval Ishay, Dvorah Rotnemer-Golinkin, Yaron Ilan. The role of the sphingosine axis in immune regulation: A dichotomy in the anti-inflammatory effects between sphingosine kinase 1 and sphingosine kinase 2-dependent pathwaysInternational Journal of Immunopathology and Pharmacology 2021; 35: 205873842110532 doi: 10.1177/20587384211053274
12
Yaron Ilan. Future of Treatment for Nonalcoholic Steatohepatitis: Can the Use of Safe, Evidence-Based, Clinically Proven Supplements Provide the Answer to the Unmet Need?Digestive Diseases and Sciences 2018; 63(7): 1726 doi: 10.1007/s10620-018-5080-x
13
Ariel Kenig, Tal Keidar-Haran, Henny Azmanov, Asa Kessler, Yotam Kolben, Tamar Tayri-Wilk, Nir Kalisman, Sarah Weksler-Zangen, Yaron Ilan. Low-Dose Colchicine Attenuates Sepsis-Induced Liver Injury: A Novel Method for Alleviating Systemic InflammationInflammation 2023; 46(3): 963 doi: 10.1007/s10753-023-01783-9
14
Zhan Liu, Peng Li, Zhi-Hong Zhao, Yu Zhang, Zhi-Min Ma, Shuang-Xi Wang. Vitamin B6 Prevents Endothelial Dysfunction, Insulin Resistance, and Hepatic Lipid Accumulation inApoe−/−Mice Fed with High-Fat DietJournal of Diabetes Research 2016; 2016: 1 doi: 10.1155/2016/1748065
15
Yehudit Shabat, Yoav Lichtenstein, Yaron Ilan. Short-Term Cohousing of Sick with Healthy or Treated Mice Alleviates the Inflammatory Response and Liver DamageInflammation 2021; 44(2): 518 doi: 10.1007/s10753-020-01348-0
16
Tahel Ilan-Ber, Yaron Ilan. The role of microtubules in the immune system and as potential targets for gut-based immunotherapyMolecular Immunology 2019; 111: 73 doi: 10.1016/j.molimm.2019.04.014
17
A. Drori, D. Rotnemer-Golinkin, S. Avni, A. Drori, O. Danay, D. Levanon, J. Tam, L. Zolotarev, Y. Ilan. Attenuating the rate of total body fat accumulation and alleviating liver damage by oral administration of vitamin D-enriched edible mushrooms in a diet-induced obesity murine model is mediated by an anti-inflammatory paradigm shiftBMC Gastroenterology 2017; 17(1) doi: 10.1186/s12876-017-0688-4
18
Yehudit Shabat, Yaron Ilan. A synergistic effect of Cremophor and beta glucosylceramide to exert liver and sugar protectionJournal of Food Science and Technology 2017; 54(5): 1184 doi: 10.1007/s13197-017-2520-0
19
Meir Mizrahi, Ami Ben Ya'acov, Tomer Adar, Miriam Levy Sklair, Svetlana Gaska, Yaron Ilan. Oral Administration ofHoodia parvifloraAlleviates Insulin Resistance and Nonalcoholic SteatohepatitisJournal of Medicinal Food 2019; 22(12): 1189 doi: 10.1089/jmf.2019.0093